[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337667-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337667-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mettl3-mediated-the-m6a-modification-of-sf3b4-facilitates-the-development-of-non-small-cell-lung-cancer-by-enhancing-lsm4-expression","METTL3-mediated the m6A modification of SF3B4 facilitates the development of non-small cell lung cancer by enhancing LSM4 expression","","Splicing factor B subunit 4 (SF3B4) is implicated in multiple cancers, and its contribution to non-small cell lung cancer (NSCLC) progression is investigated with a focus on the METTL3-mediated m6A axis. Quantitative PCR, western blot, functional assays, and RNA-protein interaction approaches evaluate SF3B4, LSM4, and METTL3 effects on proliferation, apoptosis, invasion, migration, and stemness. In NSCLC, SF3B4 is elevated and linked to worse survival, and METTL3 stabilizes SF3B4 mRNA, modulating tumor growth and metastasis through LSM4.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mettl3-mediated-the-m6a-modification-of-sf3b4-facilitates-the-development-of-non-small-cell-lung-cancer-by-enhancing-lsm4-expression/337667/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mettl3-mediated-the-m6a-modification-of-sf3b4-facilitates-the-development-of-non-small-cell-lung-cancer-by-enhancing-lsm4-expression/337667.png","ImageObject",300,407,{"name":42,"@type":43},"Ava Thompson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-25","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does SF3B4 play in NSCLC development, according to the study?","Question",{"text":63,"@type":64},"SF3B4 shows high expression in NSCLC tissues and correlates with shorter overall survival. Functional assays indicate that SF3B4 knockdown reduces proliferation, invasion, migration, and stemness while promoting apoptosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does METTL3 affect SF3B4 in NSCLC?",{"text":68,"@type":64},"METTL3 promotes SF3B4 mRNA stability through m6A modification. Reducing METTL3 expression suppresses NSCLC growth, metastasis, and stemness by downregulating SF3B4.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the relationship between SF3B4 and LSM4?",{"text":72,"@type":64},"SF3B4 can interact with LSM4. The study reports that inhibition of NSCLC cell functions induced by sh-SF3B4 can be reversed by LSM4 overexpression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337667,1790193336,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":124,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","DOI: 10.1111/1759-7714.15275  \nORIGINA L ARTICLE  \nMETTL3-mediated the m6A modification of SF3B4 facilitates the development of non-small cell lung cancer by enhancing LSM4 expression  \nGuangsi He 1,2 | Kangsheng Gu 1  | Jie Wei 3 | Jian Zhang 2  \n1Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei, China  \n2Second Department of Oncology, First People’s Hospital of Chuzhou, Chuzhou, China  \n3First Department of Oncology, First People’s Hospital of Chuzhou, Chuzhou, China  \nCorrespondence  \nKangsheng Gu, Department of Oncology, the First Affiliated Hospital of Anhui Medical University, No. 218 Jixi Road, Hefei, 230022 Anhui, China.  \nEmail: [anhui_gukangsheng@163.com](anhui_gukangsheng@163.com)  \nAbstract  \nBackground: Splicing factor B subunit 4 (SF3B4) has been confirmed to participate in the progression of many cancers and is considered to be a potential target for nonsmall cell lung cancer (NSCLC) . Thus, the role and molecular mechanism of SF3B4 in NSCLC progression deserves further study.  \nMethods: Quantitative real-time PCR and western blot were employed to detect themRNA and protein levels of SF3B4, Sm-like protein 4 (LSM4) and methyltransferaselike 3 (METTL3) . Cell proliferation, apoptosis, invasion, migration and stemness were tested by cell counting kit-8, colony formation, flow cytometry, transwell, wound healing, and sphere formation assays. The interaction between SF3B4 and METTL3 or LSM4 was confirmed by MeRIP, RIP and Co-IP assays. Mice xenograft models were constructed to assess the effects of METTL3 and SF3B4 on NSCLC tumorigenesis. Results: SF3B4 had high expression in NSCLC tissues and was associated with the shorter overall survival of NSCLC patients. Knockdown of SF3B4 suppressed NSCLC cell proliferation, invasion, migration and stemness, while inducing apoptosis. METTL3 promoted SF3B4 mRNA stability by m6A modification, and its knockdown inhibited NSCLC cell growth, metastasis and stemness by downregulating SF3B4 . SF3B4 could interact with LSM4, and sh-SF3B4-mediated the inhibition on NSCLC cell functions could be reversed by LSM4 overexpression. In addition, reduced METTL3 expression restrained NSCLC tumor growth, and this effect was reversed by SF3B4 overexpression.  \nConclusion: METTL3-stablized SF3B4 promoted NSCLC cell growth, metastasis and stemness via positively regulating LSM4 .  \nKEYW ORD S  \nLSM4, METTL3, non-small cell lung cancer, SF3B4  \nINTRODUCTION  \nNon-small cell lung cancer (NSCLC) accounts for more than 80% of all lung cancer cases, including lung squamous cell carcinoma, lung adenocarcinoma (LUAD), and large cell lung carcinoma. 1,2 Due to the lack of obvious early symptoms, most patients with NSCLC are initially diagnosed at an advanced stage and often have a poor prognosis.3,4 Importantly, tumor metastasis is also an important concern for NSCLC patients, which poses a great threat to the survival of patients.5,6 Therefore, the search for effective  \nmolecular targets that affect cancer progression is important for developing new NSCLC therapies.  \nSplicing factor B subunit 4 (SF3B4), a constituent subunit of the SF3B complex, is an important splicing factor involved in branchpoint recognition, splicing reaction activation and intron removal.7,8 SF3B4 functions as an oncogene in regulating multiple cancer processes.9,10 The role of SF3B4 in lung cancer progression has recently been widely revealed. Studies have shown that SF3B4 expression is elevated in LUAD, and its overexpression enhances LUAD cell growth.11 In addition, SF3B4 knockdown has been confirmed to repress NSCLC cell  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.  \n© 2024 The Authors. Thoracic Cancer published by John Wiley & Sons Australia, Ltd.  ","cbCail1JGRooUkST","https://ap.wps.com/l/cbCail1JGRooUkST","pdf",5807329,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n# Methods\n## Samples","[{\"question\":\"What role does SF3B4 play in NSCLC development, according to the study?\",\"answer\":\"SF3B4 shows high expression in NSCLC tissues and correlates with shorter overall survival. Functional assays indicate that SF3B4 knockdown reduces proliferation, invasion, migration, and stemness while promoting apoptosis.\"},{\"question\":\"How does METTL3 affect SF3B4 in NSCLC?\",\"answer\":\"METTL3 promotes SF3B4 mRNA stability through m6A modification. Reducing METTL3 expression suppresses NSCLC growth, metastasis, and stemness by downregulating SF3B4.\"},{\"question\":\"What is the relationship between SF3B4 and LSM4?\",\"answer\":\"SF3B4 can interact with LSM4. The study reports that inhibition of NSCLC cell functions induced by sh-SF3B4 can be reversed by LSM4 overexpression.\"}]","METTL3-mediated the m6A modification of SF3B4 facilitates the development of non-small cell lung cancer by enhancing LSM4 expression | PDF",1790020043,25,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c03b87cf38ba4fe78068b5ed8b282d2.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/994aee8ee428a2da2a72ab94f9ab7e02.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eec4ed0c3e301d7ccbee20214072e1fb.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7bb5221e5af0045764b452ffa0966b2e.webp",980,1287]